captopril has been researched along with D-fructopyranose in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, CY; Lachaal, M | 1 |
| Chen, S; Ishii, J; Kashiwabara, H; Katayama, S; Kosegawa, I | 1 |
| Chen, S; Izumida, T; Katayama, S; Noguchi, Y; Tatebe, J | 1 |
| Ho, PC; Sam, WJ | 1 |
| Mirelman, D; Miron, T; Peleg, E; Rabinkov, A; Rosenthal, T; Wilchek, M | 1 |
| Oron-Herman, M; Rosenthal, T; Sela, BA | 1 |
| Ackerman, Z; Grozovski, M; Link, G; Oron-Herman, M; Pappo, O; Rosenthal, T; Sela, BA | 2 |
| Abedi, K; Eslami, P; Nyby, MD; Smutko, V; Tuck, ML | 1 |
| Johnson, RJ; Mu, W; Nakagawa, T; Reungjui, S; Roncal, CA; Sánchez-Lozada, LG; Sautin, YY | 1 |
| Gryciuk, ME; Maciejczyk, M; Mil, KM; Pawlukianiec, C; Zalewska, A; Żendzian-Piotrowska, M; Ładny, JR | 1 |
2 review(s) available for captopril and D-fructopyranose
| Article | Year |
|---|---|
Insulin resistance and hypertension.
Topics: Adipose Tissue; Animals; Captopril; Catecholamines; Disease Models, Animal; Fructose; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Lipolysis; Monosaccharide Transport Proteins; Obesity; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY | 1992 |
Pleiotropic Properties of Valsartan: Do They Result from the Antiglycooxidant Activity? Literature Review and
Topics: Acetylcysteine; Animals; Antioxidants; Captopril; Chloramines; Chromans; Fructose; Glucose; Glycosylation; Humans; Metformin; Oxidation-Reduction; Pyruvaldehyde; Serum Albumin, Bovine; Thioctic Acid; Tosyl Compounds; Valsartan | 2021 |
9 other study(ies) available for captopril and D-fructopyranose
| Article | Year |
|---|---|
Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Child; Diet; Fructose; Glucose; Glucose Intolerance; Humans; Hyperinsulinism; Hypertension; Insulin Resistance; Male; Rats; Rats, Wistar; Tetrazoles | 1996 |
A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Captopril; Chromans; Diet; Fructose; Hypoglycemic Agents; Insulin Resistance; Male; Monosaccharide Transport Proteins; Rats; Rats, Wistar; Tetrazoles; Thiazoles; Thiazolidinediones; Troglitazone | 1996 |
Stability of captopril in invert sugar solution.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemistry, Pharmaceutical; Drug Stability; Fructose; Glucose; Hydrogen-Ion Concentration; Kinetics; Metals, Heavy | 1998 |
Allylmercaptocaptopril: a new antihypertensive drug.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Disease Models, Animal; Disulfides; Fructose; Hypertension; Hypolipidemic Agents; Insulin; Rats; Rats, Sprague-Dawley; Sulfinic Acids; Triglycerides | 2004 |
Risk reduction therapy for syndrome X: comparison of several treatments.
Topics: Amlodipine; Animals; Antihypertensive Agents; Bezafibrate; Blood Pressure; Body Weight; Captopril; Fructose; Hydrolases; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones; Triglycerides | 2005 |
Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction.
Topics: Amlodipine; Animals; Antihypertensive Agents; Bezafibrate; Blood Pressure; Captopril; Diet; Fatty Liver; Fructose; Hypolipidemic Agents; Iron; Liver; Male; Rats; Rats, Sprague-Dawley; Triglycerides | 2005 |
Vascular Angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Fructose; Heart; Hypertension; Insulin; Insulin Resistance; Male; Mesenteric Arteries; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Cell Adhesion Molecule-1; Vasculitis | 2007 |
Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liver.
Topics: Amlodipine; Animals; Antihypertensive Agents; Bezafibrate; Captopril; Fatty Liver; Fructose; Hypolipidemic Agents; Male; Metabolic Syndrome; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2008 |
Combination of captopril and allopurinol retards fructose-induced metabolic syndrome.
Topics: Allopurinol; Angiotensin-Converting Enzyme Inhibitors; Animal Feed; Animals; Antimetabolites; Body Weight; Captopril; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Energy Metabolism; Fructose; Insulin Resistance; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley | 2009 |